Berenberg initiated coverage of Zealand Pharma with a Buy rating and DKK 815 price target. The analyst views Zealand as an attractive obesity investment opportunity due to its “differentiated pipeline and wealth of near-term clinical catalysts.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on ZLDPF: